|
| 36115772 | Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. | Eur Urol | 2023 |
| 37661807 | Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others. | Am J Surg Pathol | 2023 |
| 37659445 | Quality Management System in Clinical Digital Pathology Operations at a Tertiary Cancer Center. | Lab Invest | 2023 |
| 37883726 | Biospecimen Repositories in Low- and Middle-Income Countries: Insights From an American University of Beirut and Memorial Sloan Kettering Collaboration. | JCO Glob Oncol | 2023 |
| 37811334 | Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational cost. | J Pathol Inform | 2023 |
| 37014042 | Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. | Cancer Res | 2023 |
| 37243318 | Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations. | Pediatr Blood Cancer | 2023 |
| 36538386 | Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection. | Arch Pathol Lab Med | 2023 |
| 34003251 | Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology. | Arch Pathol Lab Med | 2022 |
| 35676169 | Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy. | Clin Genitourin Cancer | 2022 |
| 35731998 | Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype. | JCO Precis Oncol | 2022 |
| 35797510 | DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient. | JCO Precis Oncol | 2022 |
| 35430756 | NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity. | Genes Chromosomes Cancer | 2022 |
| 35758203 | Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series. | Histopathology | 2022 |
| 35363038 | Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer. | J Urol | 2022 |
| 35753824 | Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. | Mayo Clin Proc | 2022 |
| 37145713 | Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort. | Urol Pract | 2022 |
| 36654741 | An update on computational pathology tools for genitourinary pathology practice: A review paper from the Genitourinary Pathology Society (GUPS). | J Pathol Inform | 2022 |
| 36536472 | Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape. | Genome Med | 2022 |
| 36564410 | Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 |
| 35926808 | Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. | Hum Pathol | 2022 |
| 36323682 | FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 |
| 35288096 | Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas. | Eur Urol Focus | 2022 |
| 35184066 | Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma. | Am J Surg Pathol | 2022 |
| 35145255 | Correction: Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma. | Br J Cancer | 2022 |
| 34645985 | Publisher Correction: Integrating digital pathology into clinical practice. | Mod Pathol | 2022 |
| 34549366 | TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas. | Endocr Pathol | 2022 |
| 34754075 | Correction: Integrating digital pathology into clinical practice. | Mod Pathol | 2022 |
| 34599281 | Integrating digital pathology into clinical practice. | Mod Pathol | 2022 |
| 34161656 | Clinical utility of subclassifying positive surgical margins at radical prostatectomy. | BJU Int | 2022 |
| 32879414 | Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma. | Mod Pathol | 2021 |
| 33854184 | TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. | Mod Pathol | 2021 |
| 33793062 | Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert<sup>®</sup> Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer. | BJU Int | 2021 |
| 33904171 | Independent real-world application of a clinical-grade automated prostate cancer detection system. | J Pathol | 2021 |
| 33514585 | Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. | J Clin Pathol | 2021 |
| 33587971 | Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. | Radiother Oncol | 2021 |
| 33586274 | Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors. | Oncologist | 2021 |
| 33727698 | Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. | Mod Pathol | 2021 |
| 33664427 | New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. | Mod Pathol | 2021 |
| 33861994 | Single-cell sequencing links multiregional immune landscapes and tissue-resident TÂ cells in ccRCC to tumor topology and therapy efficacy. | Cancer Cell | 2021 |
| 33526874 | Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. | Mod Pathol | 2021 |
| 35155745 | Digital Pathology Operations at an NYC Tertiary Cancer Center During the First 4 Months of COVID-19 Pandemic Response. | Acad Pathol | 2021 |
| 35071713 | <i>CD274</i> (<i>PD-L1</i>) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract. | Bladder Cancer | 2021 |
| 34128484 | The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. | Adv Anat Pathol | 2021 |
| 34128483 | The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. | Adv Anat Pathol | 2021 |
| 34099871 | EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. | Mod Pathol | 2021 |
| 34261695 | Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. | Clin Cancer Res | 2021 |
| 34260720 | Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center. | J Am Med Inform Assoc | 2021 |
| 31813809 | Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. | Eur Urol Focus | 2021 |
| 31977510 | Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors. | Ann Surg | 2021 |